FR1217929A - Procédé de préparation du 1,1-dioxyde de la 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine et de ses sels - Google Patents

Procédé de préparation du 1,1-dioxyde de la 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine et de ses sels

Info

Publication number
FR1217929A
FR1217929A FR781736A FR781736A FR1217929A FR 1217929 A FR1217929 A FR 1217929A FR 781736 A FR781736 A FR 781736A FR 781736 A FR781736 A FR 781736A FR 1217929 A FR1217929 A FR 1217929A
Authority
FR
France
Prior art keywords
benzothiadiazine
sulfamyl
dihydro
chloro
dioxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR781736A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR1217929A publication Critical patent/FR1217929A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
    • C07D285/28—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
    • C07D285/30—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with hydrocarbon radicals, substituted by hetero atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
FR781736A 1958-03-03 1958-12-16 Procédé de préparation du 1,1-dioxyde de la 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine et de ses sels Expired FR1217929A (fr)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US71845258A 1958-03-03 1958-03-03
US72724258A 1958-04-09 1958-04-09
US74058258A 1958-06-09 1958-06-09
US75162058A 1958-07-29 1958-07-29
US76448258A 1958-09-29 1958-09-29
DEC0028408 1959-02-27
DEC0024177 1959-02-27
DEC0024176 1959-02-27
DEC0024178 1959-02-27
DEC0028409 1959-02-27

Publications (1)

Publication Number Publication Date
FR1217929A true FR1217929A (fr) 1960-05-06

Family

ID=27579177

Family Applications (2)

Application Number Title Priority Date Filing Date
FR781736A Expired FR1217929A (fr) 1958-03-03 1958-12-16 Procédé de préparation du 1,1-dioxyde de la 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine et de ses sels
FR788246A Expired FR1264468A (fr) 1958-03-03 1959-03-03 Procédé de préparation de 1, 1-dioxydes de la sulfamyl-1-3, 4-dihydro-1, 2, 4-benzothiadiazine

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR788246A Expired FR1264468A (fr) 1958-03-03 1959-03-03 Procédé de préparation de 1, 1-dioxydes de la sulfamyl-1-3, 4-dihydro-1, 2, 4-benzothiadiazine

Country Status (6)

Country Link
CH (4) CH371454A (fr)
DE (4) DE1445007A1 (fr)
FR (2) FR1217929A (fr)
GB (1) GB861367A (fr)
MY (1) MY6200051A (fr)
OA (2) OA01178A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364894A1 (fr) * 1976-09-20 1978-04-14 Degussa Procede pour la fabrication de cyanure de benzoyle

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3200117A (en) * 1962-10-03 1965-08-10 Hoffmann La Roche Derivatives of 1, 2, 4-benzothiadiazine-7-sulfonamide-1, 1-dioxide
DE8700284U1 (fr) * 1987-01-07 1987-04-30 Ernst Reiner Gmbh & Co Kg, 7743 Furtwangen, De
JP2002504481A (ja) * 1998-02-18 2002-02-12 ニューロサーチ、アクティーゼルスカブ 新規化合物及び陽性ａｍｐａレセプターモジュレーターとしてこれを使用する方法
US6943159B1 (en) 1998-02-18 2005-09-13 Neurosearch A/S Compounds and their use as positive AMPA receptor modulators
GEP20074134B (en) 2002-08-19 2007-06-25 Pfizer Prod Inc Combination therapy for hyperproliferative diseases
US7235543B2 (en) 2003-03-07 2007-06-26 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
ATE418551T1 (de) 2003-03-07 2009-01-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
CA2905438A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
CA2913737A1 (fr) 2013-06-05 2014-12-11 Synergy Pharmaceuticals, Inc. Agonistes ultra-purs de guanylate cyclase c, leur procede de production et d'utilisation
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364894A1 (fr) * 1976-09-20 1978-04-14 Degussa Procede pour la fabrication de cyanure de benzoyle

Also Published As

Publication number Publication date
CH387642A (de) 1965-02-15
OA01178A (fr) 1969-01-25
DE1445006B2 (fr) 1975-05-07
DE1445008A1 (de) 1968-10-24
FR1264468A (fr) 1961-06-23
DE1445007A1 (de) 1968-10-24
MY6200051A (en) 1962-12-31
DE1445005A1 (de) 1968-10-24
CH371454A (de) 1963-08-31
OA03826A (fr) 1971-12-24
CH377365A (de) 1964-05-15
CH376514A (de) 1964-04-15
DE1445574A1 (de) 1969-01-16
DE1445006A1 (de) 1968-10-24
GB861367A (en) 1961-02-22
DE1112079B (de) 1961-08-03

Similar Documents

Publication Publication Date Title
FR1217929A (fr) Procédé de préparation du 1,1-dioxyde de la 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine et de ses sels
CH392555A (fr) Procédé de préparation d'a-aminoisobutyrophénones
BE581589A (fr) Derives du 7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxyde disubstitués en position 3, et leur procédé de préparation.
BE578721A (fr) Procédé pour la préparation de nucléotides de 5-fluoro-uracile.
BE576304A (fr) Procédé de préparation de 1,1-dioxydes de la sulfamyl-3,4-dihydro -1,2,4-benzothiadiazine
CH402867A (fr) Procédé de préparation de nouvelles phénothiazines
CH440301A (fr) Procédé pour la préparation de bioxydes de benzothiadiazines substituées
CH384577A (fr) Procédé de préparation de nouvelles phénothiazines
FR1247335A (fr) Procédé de préparation de 1,1-dioxydes de la 2,3-dihydro-benzo-isothiazole-3-one et de leurs sels
CH391706A (fr) Procédé de préparation de nouvelles phénothiazines
FR1272913A (fr) Procédé de préparation des 5-alkyl-2-p-halogénobenzènesulfonamido-1, 3, 4-thiadiazoles
BE583907A (fr) Procédé de préparation de 1,1-dioxydes des sulfamyl-pyrido[2,3-e] -1,2,4-thiadiazines
FR1291517A (fr) Procédé pour la préparation de dérivés du bioxyde-1, 1-de benzothiadiazine
CH381690A (fr) Procédé de préparation de nouvelles phénothiazines
FR1271046A (fr) Procédé de préparation de 1, 1-dioxydes de la sulfamyl-3, 4-dihydro-1, 2, 4-benzothiadiazine
BE583943A (fr) Procédé pour la préparation de 1,1-dioxydes des sulfamyl-3,4-dihydro-pyrido-1,2,4-thiadiazines
FR1263223A (fr) Procédé de préparation de l'alpha-l-glutamyl choline et de ses sels
FR1224766A (fr) Procédé de préparation de 1,2,4-benzothiadiazine-1,1-dioxydes
FR1341458A (fr) Procédé de préparation du 6-chloro-7-sulfamyl-3, 4-dihydro-1, 2, 4-benzothiadiazine-1, 1-dioxyde
FR1223441A (fr) Procédé de préparation de sels d'ammonium polyméthylène-bis-quaternaires hétérocycliques
FR1337762A (fr) Procédé de préparation de 3, 4-dihydro-1, 2, 4-benzothiadiazine-1, 1-dioxydes substitués
FR1239023A (fr) Procédé de préparation d'aminoalcoyl-hydroxyaryl-cétones, aminoalcoyl-alcoxyarylcétones et aminoalcoyl-alcoylthioaryl-cétones
FR1328585A (fr) Procédé de préparation du 2,5-dihydrothiophène et de divers sels s-substitués
BE617986A (fr) Procédé de préparation de 3-oxo-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes substitués en position 2
FR1481002A (fr) Procédé de préparation de 3, 4-dihydro-1, 2. 4-benzothiadiazine-1, 1-dioxydes